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Purpose: The 65 kDa retinal pigment epithelium-specific protein, RPE65, is an essential enzyme for 11-cis-retinal
synthesis in the eye. Mutations of the RPE65 gene in humans result in severe vision loss, and Rpe65−/− mice show early
cone photoreceptor degeneration. We used an explant culture system to evaluate whether posttranslational downregulation
of M-opsin protein in Rpe65−/− mice is caused by proteolytic degradation.
Methods: The eyes of three-week-old Rpe65−/− mice were incubated in culture medium. Western blot analysis was used
to evaluate the level of M-opsin protein, and immunofluorescence was used for protein localization. The transcriptional
level of M-opsin was evaluated with real-time reverse-transcriptase-PCR.
Results: Degradation of the M-opsin protein in Rpe65−/− mouse retina was inhibited by the proteasome inhibitor MG-132
but not by the lysosomal inhibitor pepstatin A and E64d. 9-cis-retinal, used as an analog of 11-cis-retinal, increased M-
opsin protein but did not increase M-opsin mRNA. Moreover, 9-cis-retinal did not change the transcriptional levels of
photoreceptor specific genes.
Conclusions: Our data suggest that M-opsin protein was degraded through a proteasome pathway and that M-opsin
degradation was suppressed with 9-cis-retinal treatment in Rpe65−/− mice to some extent.
Photon absorption initiates phototransduction in retinal
photoreceptors  and  is  essential  for  vision  in  the  eye.
Absorption occurs via the chromophore 11-cis-retinal binding
apo-protein, opsin [1]. After absorption of a photon, 11-cis-
retinal is isomerized to all-trans-retinal [2] and regenerated
by  a  series  of  retinoid  metabolism  transformations  of
enzymatic reactions called the retinoid cycle [3].
The retinal pigment epithelium-specific protein 65 kDa
(RPE65)  has  been  identified  as  the  catalyst  for  the
isomerization of all-trans-retinyl esters, which is converted
from  all-trans-retinol  (vitamin  A)  by  lecithin-retinol
acyltransferase (LRAT), to 11-cis-retinol in the visual cycle
pathway [4-7]. RPE65 plays a critical role in the production
of 11-cis-retinal; Rpe65−/− mice cannot generate 11-cis-retinal
[7]. Measurement of visual function with electroretinogram
(ERG) in Rpe65−/− mice showed almost no response [8-10].
Photoreceptors  have  been  described  as  degenerated  in
Rpe65−/−  mice  and  Rpe65  mutant  mice  [11-14]  like  other
models of retinitis pigmentosa [15]. Further, mutation of the
RPE65 gene is the cause of Leber congenital amaurosis Type
2 and retinitis pigmentosa [16-19]. These reports indicate that
11-cis-retinal synthesis by RPE65 is essential for maintaining
photoreceptor cells and visual function in mouse and human
retinas.
Correspondence  to:  Mitsuru  Nakazawa,  Department  of
Ophthalmology, Hirosaki University Graduate School of Medicine,
5 Zaifu-cho, Hirosaki, Aomori 036-8562, Japan; Phone: +81 172 39
5094; FAX: +81 172 37 5735; email: mitsuru@cc.hirosaki-u.ac.jp
Moreover,  11-cis-retinal  and  other  retinoids  have
potential as pharmacological chaperones. Opsin stability is
increased  by  binding  11-cis-retinal  in  vitro  [20-22].  We
previously reported that M-opsin mRNA levels in Rpe65−/−
mice at three and five weeks of age were not significantly
different from those of wild-type mice. In contrast, M-opsin
protein expression was at a low level [23]. These observations
suggest  that  M-opsin  protein  has  decreased  stability  and
undergoes proteolysis in Rpe65−/− mice lacking 11-cis-retinal.
Znoiko et al. [11] previously reported, however, that M-opsin
mRNA was downregulated in Rpe65−/− mice at early ages.
Recently, Zhang et al. [24] reported M-opsin protein was
markedly  reduced  in  gene  encoding  LRAT  (Lrat−/−)  mice
whereas the S-opsin level remained the same compared with
wild-type  mice.  The  results  also  suggested  that  M-opsin
degradation occurred posttranslationally in the absence of a
chromophore, 11-cis-retinal.
In  the  current  study,  we  evaluated  whether
posttranslational  downregulation  of  M-opsin  protein  in
Rpe65−/−  mice  was  caused  by  proteolytic  degradation.  To
characterize M-opsin degradation, we used three inhibitors:
pepstatin  A  (aspartic  protease  inhibitor),  E64d  (cysteine
protease  inhibitor),  and  MG-132  (proteasome  inhibitor).
Additionally,  we  evaluated  whether  posttranslational
downregulation  of  M-opsin  protein  in  Rpe65−/−  mice  was
caused by 11-cis-retinal depletion. Instead of 11-cis-retinal,
we used the chromophore 9-cis-retinal because 9-cis-retinal
also binds with apo-opsins to form functional pigments and is
known to be relatively stable as an analog to 11-cis-retinal
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1516[8,25].  The  present  study  focused  on  determining  the
degradation pathway of M-opsin protein in Rpe65−/− mice and
whether the degradation was prevented by 9-cis-retinal.
METHODS
Animals:  All  experimental  procedures  were  designed  to
conform ethically to the Association for Research in Vision
and Ophthalmology (ARVO) Statement for Use of Animals
in  Ophthalmic  Vision  Research  and  Hirosaki  University
Guidelines  for  Animals  in  Research.  Rpe65−/−  mice  were
generously provided by Matthew M. LaVail (University of
California,  San  Francisco,  CA)  and  T.  Michael  Redmond
(National Eye Institute, Bethesda, MD). C57BL/6 mice were
obtained from Clea (Tokyo, Japan) and used as wild-type
animals. Animals were maintained in the Hirosaki University
Graduate School of Medicine Animal Care Service Facility
under a cycle of 12-h light (50 lux illumination in the cage)
and  12-h  dark  (<10  lux  of  environmental  illumination).
Experiments were performed on three-week-old mice.
Explant culture: Eyes of wild-type and Rpe65−/− mice were
enucleated, and the corneas were removed on ice under the
stereo  microscope.  The  superior  edges  of  eyecups  were
partially cut with a surgical knife for orientation. The eyecups
were  then  rinsed  with  Hanks’  Balanced  Saline  Solution
(HBSS; Nissui Pharmaceutical, Tokyo, Japan) and incubated
in culture medium. Culture medium was a composite made of
50% Dulbecco’s modified Eagle’s Medium (DMEM; Nissui
Pharmaceutical), 25% fetal bovine serum, and 25% HBSS
supplemented with 2 mM L-glutamine, 5.75 mg/ml glucose,
and antibiotics (100 μg/ml streptomycin and 100 units/ml
penicillin; Wako Pure Chemical Industries, Osaka, Japan)
according to the Osakada et al. [26] modification. Four eyes
were incubated in 3 ml culture medium in each well with 6-
well plates purchased from NuncTM (Thermo Fisher Scientific,
Roskllide,  Denmark)  and  maintained  in  a  humidified
atmosphere of 5% CO2 and 95% air at 37 °C. Pepstatin A,
E64d (Peptide institute, Osaka, Japan), and MG-132 (Sigma-
Aldrich,  St.  Louis,  MO)  were  dissolved  with  a  final
concentration of 1% dimethyl sulfoxide (DMSO; Wako), and
9-cis-retinal (Sigma-Aldrich) was dissolved with 1% ethanol
(Wako). After incubation with protease inhibitors or 9-cis-
retinal,  retina-RPE  choroids  were  collected  for  western
blotting and for real-time reverse-transcriptase polymerase
chain reaction (RT–PCR), and the eyecups were used for the
cryosections. The explant culture was performed in a CO2
incubator under dark conditions.
Preparation of retinal sections: After treatment with protease
inhibitors or 9-cis-retinal, eyecups were first embedded in
OCT  compound  (Sakura,  Tokyo,  Japan),  and  then
cryosections were made at a thickness of 5 μm in cryostat.
Sections were fixed with 4% paraformaldehyde in phosphate-
buffer  (PB;  pH  7.4)  for  15  min  before  various  staining
experiments. The superior hemispheres of the eyecups were
employed for subsequent experiments.
Hematoxylin and eosin staining: Hematoxylin staining was
performed with Carrazzi’s hematoxylin solution (Muto Pure
Chemicals,  Tokyo,  Japan)  for  5  min.  After  a  wash  with
running water, eosin staining was performed with 1% eosin Y
solution (Muto Pure Chemicals) for 1 min. The sections were
washed and dehydrated with ethanol of serial dilution and
enclosed with MGK-S (Matsunami Glass, Osaka, Japan).
Terminal deoxynucleotidyl transferase-mediated dUTP nick-
end labeling staining: Terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP nick-end labeling (TUNEL) staining
was  conducted  with  an  in  situ  Apoptosis  Detection  Kit
(Takara,  Osaka,  Japan)  according  to  the  manufacturer’s
instruction.
Western blotting: Retina-RPE choroids were homogenized
with homogenate buffer, and the protein concentration was
measured according to the methods previously reported [23].
Sodium  dodecyl  sulfate–PAGE  was  performed  with  10%
acrylamide.  Separated  proteins  were  transferred  to  the
polyvinylidene  difluoride  membrane  (Bio-Rad,  Hercules,
CA), and M-opsin was detected as previously described [23].
Briefly,  the  membrane  was  blocked  for  1  h  at  room
temperature with 1% normal goat or rabbit (for S-opsin only)
serum in 0.05% Tween-20 in phosphate-buffered saline (Tw-
PBS; 137 M NaCl, 10 M phosphate, 2.7 M KCl and a pH
7.4).abbit  anti-L/M-opsin  antibody  (described  as  anti-M-
opsin  antibody;  0.2  µg/ml;  Chemicon  International,
Temecula,  CA),  goat  antiblue  sensitive  opsin  antibody
(described as anti-S-opsin antibody; 0.04 µg/ml; Santa Cruz
Biotechnology,  Delaware,  CA),  mouse  antirhodopsin
antibody (0.02 µg/ml; Chemicon International), rabbit anti-
GNAT2 (cone transducin α) antibody (0.2 µg/ml; Abcam,
Cambridge, MA), or rabbit anti-GNAT1 (rod transducin α)
antibody  (0.5  µg/ml;  Abcam)  was  used  as  the  primary
antibody, respectively, and the membranes were incubated
with diluted antibody overnight at 4 °C. After the membranes
were  washed  three  times  with  Tw-PBS,  horseradish
peroxidase  (HRP)-conjugated  goat  antirabbit
immunoglobulin  G  (IgG)  (0.05  µg/ml;  Dako,  Cambridge,
UK) or rabbit antigoat IgG (for detecting S-opsin; 0.05 µg/ml;
Dako)  was  used  as  the  secondary  antibody,  and  the
membranes  were  incubated  at  room  temperature  for  1  h.
Immunoreactive signals were developed with ECL western
blotting detection reagents (GE Healthcare, Piscataway, NJ),
and the immunoreactive bands were captured with LAS3000
mini  (Fujifilm,  Tokyo,  Japan).  For  detecting  bands  of
glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)  and
β-actin, polyvinylidene difluoride membranes were reblotted
with  the  ReBlot  Western  Blot  Recycling  Kit  (Chemicon
International), and rabbit anti-GAPDH antibody (0.02 µg/ml;
Abcam) or mouse anti-β-actin antibody (0.1 µg/ml; Abcam)
was used as the primary antibody. The integrated density of
each band was quantified by using ImageJ software.
Immunohistochemistry: Sections were rinsed with PBS and
were quenched of endogenous peroxidase activity with 0.3%
Molecular Vision 2012; 18:1516-1525 <http://www.molvis.org/molvis/v18/a157> © 2012 Molecular Vision
1517H2O2 in methanol for 15 min at room temperature to minimize
background. After being washed with Tw-PBS, sections were
blocked with 5% skim milk in Tw-PBS for 2 h. Rabbit anti-
M-opsin antibody was diluted in blocking buffer (1:4,000) and
applied overnight at 4 °C. Sections were then washed in Tw-
PBS and treated with HRP-conjugated goat antirabbit IgG
(1:500; Dako) overnight at 4 °C. After being washed with Tw-
PBS,  sections  were  incubated  with  tetrametylrhodamine-
labeled tyramide (PerkinElmer Inc., Waltham, MA) for 10
min at room temperature. Following this procedure, sections
were washed with Tw-PBS and mounted with Vectashield
(Vector,  Burlingame,  CA)  containing  4’-6’-diamidino-2-
phenylindole (DAPI) to stain nuclei. Micrographs were taken
from retinas randomly at 200× magnification, and the area of
immunoreactivity with anti-M-opsin antibody in six regions
of section was quantified using ImageJ software.
Quantitative  reverse-transcriptase  polymerase  chain
reaction: Retina-RPE choroids were isolated, and total RNA
was extracted from them with Isogen (Nippon Gene, Osaka,
Japan). Then, cDNA were generated as described previously
[23]. Briefly, RNA (1 µg each) was used to generate first
strand cDNA with a first-strand cDNA Synthesis kit for RT–
PCR  (Roche  Applied  Science,  Indianapolis,  IN).  PCR
amplifications were conducted using SYBR Premix Ex taq
(Takara) and 0.2 μM of each forward and reverse primer.
Primers to amplify genes were as follows: M-opsin (forward:
5′-CTC TGC TAC CTC CAA GTG TGG-3′, reverse: 5′-AAG
TAT AGG GTC CCC AGC AGA-3′); S-opsin (forward: 5′-
TGT ACA TGG TCA ACA ATC GGA-3′, reverse: 5′-ACA
Figure 1. Histologic analysis of wild-type retina in vivo and after explant culture. The cryosections of wild-type retina in vivo (A) and for 24
h incubation after explant culture (B) were stained with hematoxylin and eosin. RPE, retinal pigment epithelium; ONL, outer nuclear layer;
INL, inner nuclear layer. Scale bars=100 μm.
Figure 2. Detection of apoptotic cells with TUNEL staining. Wild-type retina in vivo as negative control (A), explant culture of the wild-type
retina for 12 h (B), and 24 h incubation (C). Blue: nuclear staining with DAPI. Green: TUNEL-positive staining indicated by arrows. ONL,
outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Scale bars=100 μm.
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1518CCA TCT CCA GAA TGC AAG-3′); rhodopsin (forward: 5′-
CAA GAA TCC ACT GGG AGA TGA-3′, reverse: 5′-GTG
TGT  GGG  GAC  AGG  AGA  CT-3′);  guanine  nucleotide
binding protein cone-specific transducin α-subunit (GNAT2;
forward: 5′-GCA TCA GTG CTG AGG ACA AA-3′, reverse:
5′-CTA  GGC  ACT  CTT  CGG  GTG  AG-3′);  GNAT1
(forward:  5′-GAG  GAT  GCT  GAG  AAG  GAT  GC-3′,
reverse: 5′-TGA ATG TTG AGC GTG GTC AT-3′), and β-
actin (forward: 5′-GCT ACA GCT TCA CCA CCA CA-3′,
reverse: 5′-TCT CCA GGG AGG AAG AGG AT-3′) [11,
23]. Real-time RT–PCR reaction and normalization with β-
actin were performed using previously published methods
[23]. Briefly, reaction was performed under the fo;;owing
cycling conditions: 95 °C for 10 s; and 26–40 cycles of 95 °C
for 5 s and 60 °C for 20 s with LightCycler (Roche Applied
Science).  The  specificity  of  amplication  reactions  was
confirmed  by  melting-curve  analysis  and  amplified  PCR
fragments were electrophoresed in a 1.5% agarose gel and
visualized by ethidium bromide. A dilution series of cDNA
samples  was  used  to  generate  a  standard  curve  and
quantitative  values  of  target  genes  were  obtained  with
LightCycler software according to the manual. Expression
levels of target genes were normalized by β-actin level in each
sample.
Statistical analyses: Statistical analyses of the target protein
and gene expression were performed with an unpaired Student
t test.
RESULTS
The effect of explant culture on wild-type retina: We analyzed
retinal sections to evaluate the explant culture method. Eyes
of wild-type (C57BL/6) mice were cultured and stained with
hematoxylin and eosin. After 24 h of explant culture, the outer
retinal  structure  was  relatively  preserved  (Figure  1).  In
addition,  TUNEL  staining  was  performed  to  investigate
whether apoptosis was induced by the explant culture itself in
the retina. In the wild-type mice retina, TUNEL-positive cells
were only rarely visible after 12 h and 24 h of explant culture
(Figure 2).
Level  of  M-opsin  protein  in  the  presence  of  a  protease
inhibitor mixture in Rpe65−/− mice retina: The amount of M-
opsin protein in the retina treated with a protease inhibitor
mixture  (20  μM  pepstatin  A,  30  μM  E64d,  and  10  μM
MG-132) was higher than that of M-opsin in the control retina
for 24 h in Rpe65−/− mice (Figure 3A). M-opsin protein was
mainly localized to cone outer segments (COS) by vehicle
treatment for 24 h in Rpe65−/− mice. In contrast, M-opsin
protein was found in cone outer segments, the outer nuclear
layer (ONL), and the outer plexiform layer (OPL) in Rpe65−/
− mouse eyes treated with the protease inhibitor mixture for
24 h (Figure 3B). M-opsin-positive cells increased in cone
outer segments (arrows) and notably appeared in the ONL and
the OPL (arrowheads) with 24-h treatment with the protease
inhibitor mixture. Immunohistochemistry revealed the area of
immunoreactivity  with  anti-M-opsin  antibody  was
significantly increased in retinas treated with the protease
inhibitor mixture compared to control (an approximate 2.6
fold difference, p=0.0273, Figure 3C).
Levels  of  M-opsin  protein  with  the  treatment  of  protease
inhibitors  in  Rpe65−/−  mice  retina:  To  investigate  which
protease inhibitor was most effective on M-opsin degradation,
protease inhibitors were used independently to treat eyes of
Rpe65−/− mice. Treatment with 20 μM pepstatin A or 30 μM
E64d for 24 h did not change the level of M-opsin protein
compared with vehicle treatment (Figure 4A,B). However,
Figure 3. Western blotting and immunohistochemistry analysis of
M-opsin expression treated with a protease inhibitor mixture (20
μM pepstatin A, 30 μM E64d, and 10 μM MG-132) for 24 h in
Rpe65−/− mice in retinal explants. A: Immunoblots were performed
using  retina-RPE  choroids  treated  with  the  protease  inhibitor
mixture. A loading control with GAPDH was included for each
immunoblot. B: Immunolocalization of M-opsin protein in the retina
treated with a protease inhibitor mixture. M-opsin was stained with
polyclonal anti-M-opsin antibody (red), and cell nuclei were labeled
with DNA-binding dye DAPI (blue). The number of immunoreactive
products increased in the cone outer segments (arrows), ONL, and
OPL  (arrowheads).  C:  Histograms  showing  the  area  of
immunoreactivity of M-opsin in a 400-μm-wide section of the retina.
Data are expressed as the mean±SD (n=6). *p<0.05. RPE, retinal
pigment epithelium; OS, outer segment; ONL, outer nuclear layer;
OPL, outer plexiform layer. Scale bars, 50 μm.
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15192 μM or 10 μM MG-132 treatment for 24 h increased the
amount of M-opsin protein compared with control (Figure
4C). We then tried to evaluate the effect of MG-132 on the
protein level of not only M-opsin but also other photoreceptor
specific proteins including S-opsin, rhodopsin, GNAT1, and
GNAT2,  respectively.  Results  showed  that  MG-132
specifically  and  significantly  (p<0.01)  inhibited
downregulation of M-opsin at the protein level compared with
vehicle treatment while the S-opsin, rhodopsin, GNAT1, and
GNAT2  levels  were  not  different  between  MG-132  and
vehicle (Figure 4D,E). MG-132 treatment also increased M-
opsin-expressing cells in the area of cone outer segments
(arrows), the ONL, and the OPL (arrowheads; Figure 4F).
Quantitative  analysis  was  performed  on  the
immunohistochemistry;  the  area  of  M-opsin
immunoreactivity was significantly increased by treating with
2  μM  MG-132  (approximately  2.0  fold,  p=0.0108)  and
10 μM MG-132 (approximately 2.4 fold, p<0.0001) compared
to the control, respectively (Figure 4G).
The  effect  of  9-cis-retinal  treatment  on  M-opsin  protein
expression  in  Rpe65−/−  mice:  To  determine  whether  the
degradation of the M-opsin protein was caused by depletion
of  11-cis-retinal  in  Rpe65−/−  mice,  9-cis-retinal  was
substituted for 11-cis-retinal. The levels of M-opsin protein
expression increased in the Rpe65−/− mice retinas treated with
0.5  nM  9-cis-retinal  for  24  h  (Figure  5A).  High
immunoreactivity  to  M-opsin  with  0.5  nM  9-cis-retinal
treatment compared to vehicle treatment was detected in cone
outer segments (arrows), the ONL, and the OPL (arrowheads)
with  immunohistochemistry  (Figure  5B).  M-opsin  protein
was only slightly detectable in the ONL and the OPL of the
vehicle-treated  retinas,  but  M-opsin-positive  cells  were
present in these areas with the treatment of 0.5 nM 9-cis-
retinal.  The  signal  intensity  of  the  probed  anti-M-opsin
antibody  was  measured  to  determine  quantity.
Immunohistochemistry showed the area of M-opsin reactivity
was significantly increased with treatment by 0.5 nM 9-cis-
retinal; a 2.5 fold increase (p=0.0006) was seen relative to
vehicle treatment (Figure 5C).
Treatment with 0.5 nM 9-cis-retinal for 6 or 12 h also
significantly  increased  the  levels  of  M-opsin  protein
compared  with  control  (p<0.01)  while  S-opsin,  GNAT2,
GNAT1, and rhodopsin did not show any difference at the
protein  level  between  9-cis-retinal  and  vehicle  treatment
(Figure 6A,B). GAPDH western blots did not differ between
0.5 nM 9-cis-retinal treatment and vehicle treatment, but the
slight decrease in the GAPDH protein levels depends on the
culture time while the expression of β-actin showed constant
levels during the culture time (Figure 6A). Treatment with a
protease inhibitor mixture for 12 h increased the level of M-
opsin protein in the retinas of Rpe65−/− mice but not wild-type
mice (Figure 6C,D).
The effect of 9-cis-retinal on the expression of photoreceptor
genes in Rpe65−/− mice: We used real-time RT–PCR analysis
to evaluate transcriptional levels in retina-RPE choroids from
Rpe65−/− mice treated with 9-cis-retinal for 12 h. The relative
amounts of cone photoreceptor specific gene (M-opsin, S-
opsin and GNAT2; cone transducin α subunit) mRNAs were
not  different  between  vehicle  and  0.5  nM  9-cis-retinal
treatment (Figure 7A-C). The expression levels of mRNA of
rod photoreceptor specific genes (rhodopsin and GNAT1; rod
transducin α subunit) also did not differ significantly between
0.5  nM  9-cis-retinal  treatment  and  vehicle  treatment  in
Rpe65−/− mice (Figure 7D,E).
DISCUSSION
Previously, we reported that the transcriptional level of M-
opsin in Rpe65−/− mice was not significantly different from
that of wild-type mice at three or five weeks of age [23].
However,  protein  levels  of  M-opsin  were  dramatically
decreased in Rpe65−/− mice compared with wild-type mice
[23]. These results indicate that M-opsin protein may degrade
faster  in  Rpe65−/−  mice  than  in  wild-type  mice.  Although
Znoiko et al. [11] reported that M-opsin was transcriptionally
downregulated in the Rpe65−/− mice, they did not examine M-
opsin expression at the protein level. In addition, their RT–
PCR methods [11] were different from our previous reports
[23]. The main differences include the quantitative analysis
methods  (their  ΔΔCt  method  versus  our  standard  curve
analysis), reference genes (18S rRNA versus β-actin mRNA),
and  primers  to  generate  cDNA  (oligo  dT  versus  random
primers). These differences in RT–PCR methods may have
produced different results. In the present study, to evaluate our
hypothesis of the posttranslational degradation of M-opsin,
we used explant cultures. The present study demonstrated that
M-opsin protein in Rpe65−/− mice degraded more than that of
wild-type mice and that the degradation was specifically and
significantly inhibited by MG-132 or 9-cis-retinal treatment.
These results suggest that 11-cis-retinal contributes to the
stability  of  M-opsin  protein  and  that  depletion  of  11-cis-
retinal  induces  the  degradation  of  M-opsin  protein  via  a
proteasome  pathway  in  the  mouse  retina.  In  our  current
experimental conditions, however, high immunoreactivity to
M-opsin was detected not only in cone outer segments but also
in the ONL and the OPL (Figure 5B). Possibilities that may
explain these results are the concentration and/or duration of
9-cis-retinal treatment may not be enough to correct mis-
trafficking  of  M-opsin,  although  9-cis-retinal  treatment
partially  suppresses  M-opsin  degradation,  and  the  explant
condition may not be optimized for protein trafficking rather
than an in vivo condition. The latter possibility may also
explain  why  MG-132  or  9-cis-retinal  treatment  did  not
increase  the  expression  of  GNAT2,  one  of  peripheral
membrane proteins in cone outer segments. In a previous
study by Zhang et al. [12], administration of 11-cis-retinal
corrected abnormal trafficking of GNAT2, and consequently
increased its protein expression level. Their study suggests
that  not  only  cone  opsins  require  11-cis-retinal  to  fold
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1520correctly and to traffic to COS, but also other COS proteins
may  require  cone  opsins  as  guides  to  be  cotargeted  and
targeted  correctly.  In  the  present  study,  however,
administration of 9-cis-retinal did not increase the expression
of GNAT2 at the protein level (Figure 6A). The present results
suggest that COS proteins such as GNAT2 were degraded
probably because they were not targeted to COS properly due
to mis-trafficking of M-opsin. The amount of GNAT2 was not
expected  to  increase  if  neither  MG-132  nor  9-cis-retinal
seemed  to  be  able  to  correct  the  M-opsin  mis-trafficking
problem. In addition, because administration of 11-cis-retinal
to  Rpe65−/−Rho−/−  mice  also  only  partially  corrected  mis-
trafficking of M-opsin [12], trafficking of M-opsin to COS
may require other factors besides 11-cis-retinal. Further study
is needed to clarify these points.
Huber et al. [27] reported that chromophores did not
regulate gene transcription of Rh1 opsin in Drosophila, but
chromophore supply was important for stabilizing the Rh1
opsin protein. Previous studies have demonstrated that 11-
cis-retinal  regulated  stability  for  rod  opsin  [20-22].  In
addition,  the  mutant  rhodopsin  misfolded  protein  was
degraded by proteasome, and improved folding and stability
were obtained by adding chromophores [28-30]. These data
suggest that chromophores act like chaperone molecules for
the rod opsin protein. On the other hand, no study has reported
that chromophores enhance stability of cone opsins as far as
we understand. Our data indicate that chromophores play a
role  in  maintaining  the  stable  conformation  of  M-opsin
protein.
Previous  studies  have  reported  that  intraperitoneal
injection of 11-cis-retinal can restore cone ERG responses in
Figure 4. Expression of M-opsin protein in the retina after treatment with several types of protease inhibitors for 24 h in retinal explants. M-
opsin protein levels were analyzed with western blotting after treatment with (A) pepstatin A, (B) E64d, and (C) MG-132. D: Effect of MG-132
on M-opsin, S-opsin, GNAT2, GNAT1, and rhodopsin at the protein level analyzed with western blotting. E: Quantitative analysis of M-opsin
protein level. F: Immunohistochemistry in MG-132-treated retinas for 24 h showed M-opsin (red). Cell nuclei were contrasted with DAPI
(blue). M-opsin-positive cells increased after treatment with 2 μM or 10 μM MG-132 compared with vehicle in cone outer segments (arrows),
ONL, and OPL (arrowheads) in the retina. G: Densitometric analysis of immunofluorescence probed anti-M-opsin antibody in a 400-μm-
wide section of retina. Histograms indicate mean±SD (n=6). *p<0.05, **p<0.01, ***p<0.001. RPE, retinal pigment epithelium; OS, outer
segment; ONL, outer nuclear layer; OPL, outer plexiform layer. Scale bars, 50 μm.
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1521Rpe65−/− mice and Rpe65−/−Rho−/− mice [10,31]. These data
suggest that available exogenous 11-cis-retinal may promote
cone pigments in the mouse retina. Moreover, administration
of  9-cis-retinal  or  9-cis-retinyl  acetate  preserved  ERG
responses  in  various  mice  lacking  11-cis-retinal  and  in
Rpe65 mutant dogs [8,9,32-35]. These studies indicate that 9-
cis-retinal  is  also  useful  as  a  chromophore,  and  visual
pigments  are  generated  by  exogenous  9-cis-retinal.  Our
results  showed  that  9-cis-retinal  treatment  prevented
degradation  of  M-opsin  protein  in  Rpe65−/−  mice.  These
observations  indicate  that  chromophore-free  M-opsin
pigments  are  degraded  and  endogenous  11-cis-retinal  is
critical for the stability of M-opsin protein in the mouse retina.
Figure 5. Effect of 9-cis-retinal on M-opsin expression in Rpe65−/−
mice in retinal explants. A: Retina-RPE choroids incubated with 0.5
nM or 5 nM 9-cis-retinal for 24 h were used for western blotting to
detect M-opsin protein. B: Immunolocalization of M-opsin treated
0.5  nM  9-cis-retinal  for  24  h  in  the  Rpe65−/−  mice  retina.
Immunoreactivity of M-opsin (red) was higher with 0.5 nM 9-cis-
retinal treatment compared to vehicle treatment in the cone outer
segments (arrows), ONL, and OPL (arrowheads) in the retina. C:
Histological findings of the density on the reactions labeled anti-M-
opsin  antibody  in  a  400-μm-wide  section  of  the  retina.  Values
represented mean ± SD (n=6). ***p<0.001. RPE, retinal pigment
epithelium; OS, outer segment; ONL, outer nuclear layer; OPL, outer
plexiform layer. Scale bars, 50 μm.
Furthermore, the degradation of M-opsin protein is prevented
when  exogenous  9-cis-retinal  is  available  to  act  as  a
Figure 6. Time course of 9-cis-retinal treatment in Rpe65−/− mice on
photoreceptor specific proteins and the inhibitory effect of a protease
inhibitor mixture on M-opsin degradation in Rpe65−/− mice and wild-
type mice at three weeks in retinal explants. A: The M-opsin, S-opsin,
GNAT2, GNAT1, and rhodopsin levels treated with 0.5 nM 9-cis-
retinal for 6, 12, or 24 h are shown with immunoblot in Rpe65−/−
mice. B: Quantitative analysis of effect of 9-cis-retinal on the M-
opsin protein level. Histograms indicate mean±SD (n=6), **p<0.01.
Western blots were performed to analyze the expression of M-opsin
protein in the retina-RPE choroids treated with a protease inhibitor
mixture (20 μM pepstatin A, 30 μM E64d, and 10μM MG-132) for
12 h in Rpe65−/− mice (C) and wild-type mice (D).
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1522chromophore. In the present study, 0.5 nM 9-cis-retinal was
effective for preserving M-opsin protein in Rpe65−/− mice to
some extent (Figure 6A). Treatment of GNAT1−/−Lrat−/− and
GNAT1−/−Rpe65−/−  mouse  eyes  with  9-cis-retinyl  acetate
restored cone-specific ERG [32]. This recovery of cone ERG
responses may be partially due to the inhibition of M-opsin
protein degradation through 9-cis-retinyl acetate treatment.
We observed a tendency for GAPDH levels to slightly
decrease in our explant culture from 6 to 24 h, although β-
actin levels maintained the same expression level (Figures 4D
and Figure 6A). These phenomena suggest that GAPDH may
either be less stable than β-actin or GAPDH expression may
be  downregulated  with  the  culture  condition.  These
possibilities need to be investigated in further studies.
We previously reported that the transcriptional level of
rhodopsin decreased in Rpe65−/− mice aged three to seven
weeks  [23].  We  concluded  that  11-cis-retinal  directly
regulated the transcriptional level of rhodopsin, and thus the
cause of downregulation of rhodopsin mRNA in Rpe65−/−
mice was depletion of 11-cis-retinal in the retina. To test this
hypothesis  in  the  current  experiments,  we  evaluated  the
Figure 7. Effect of treatment with 9-cis-retinal for the expression of
photoreceptor  specific  genes  in  Rpe65−/−  mice  at  three  weeks.
Semiquantitative real-time RT–PCR was performed to determine
transcriptional  levels  of  M-opsin  (A),  S-opsin  (B),  GNAT2  (C),
rhodopsin  (D),  and  GNAT1  (E).  No  significant  change  in  the
transcriptional levels of five genes was present between 0.5 nM 9-
cis-retinal treatment and vehicle treatment for 12 h. Values represent
mean±SD (n=6).
transcriptional level of rhodopsin with 9-cis-retinal treatment
in Rpe65−/− mice with real-time RT–PCR. The amount of
rhodopsin  mRNA  expression  in  the  9-cis-retinal  treated
retinas was not significantly different from the control in
Rpe65−/− mice (Figure 7D). In addition, the transcriptional
levels  of  other  photoreceptor  specific  genes  also  were
unchanged  (Figure  7).  These  data  demonstrate  that  the
chromophore does not directly regulate the transcriptional
expression  of  rhodopsin  and  other  photoreceptor  specific
genes. Downregulation of rhodopsin mRNA expression in
Rpe65−/− mouse retinas might indicate damage or stress on rod
photoreceptor cells.
Our data showed that the M-opsin protein level increased
in  Rpe65−/−  mice  with  MG-132  treatment,  but  not  with
pepstatin A or E64d treatment (Figure 4). Pepstatin A is an
inhibitor of cathepsin D; E64d is an inhibitor of calpains and
cathepsins  B/H/L  [36-41].  MG-132  is  an  inhibitor  of
proteasome,  cathepsins,  and  calpains.  Inhibition  of  the
degradation  of  M-opsin  protein  in  Rpe65−/−  mice  with
MG-132  treatment  implies  that  the  M-opsin  protein  is
degraded by proteasome and/or cathepsins and/or calpains.
Since pepstatin A and E64d did not inhibit the degradation of
M-opsin protein, the degradation was not due to cathepsins
and calpains. Briefly, these data indicate that the M-opsin
protein in the Rpe65−/− mouse retina may be degraded via the
proteasome pathway rather than by lysosomal enzymes. The
proteasome  system  is  required  for  maintaining  biologic
homeostasis and regulating many crucial processes in cells
[42]. Ubiquitinated proteins are degraded as substrates by 26S
proteasome,  an  adenosine-5′-triphosphate-dependent
proteolytic  complex  [43].  The  26S  proteasome  degrades
misfolded proteins, various cell cycle regulators, transcription
factors, and tumor suppressors [44,45]. M-opsin lacking 11-
cis-retinal may be a misfolding protein in Rpe65−/− mice, and
this misfolding might trigger degradation of M-opsin protein
by the proteasome system. Zhang et al. reported that M-opsin
in Lrat−/− mice was only transiently ubiquitinated before being
degraded  by  the  proteasome  [24].  Their  results  may  also
suggest  the  possibility  that  the  ubiquitinated  M-opsin  is
quickly degraded by the proteasome system.
In the retina, α-crystallin is expressed and classified as a
member  of  the  heat  shock  protein  family  of  molecular
chaperones. Deretic et al. [46] reported that α-crystallin is
associated  with  post-Golgi  membranes  concurrently  with
newly synthesized rhodopsin in frog photoreceptors. These
data suggest that α-crystallin might play a role in correct
folding of rhodopsin on post-Golgi membranes. In addition,
Griciuc et al. [47] previously reported the possibility that
misfolded rhodopsinP23H required the endoplasmic reticulum
associated  degradation  pathway  to  be  degraded  by  the
proteasome [48]. In the mouse retina, M-opsin protein might
also regulate folding and stability by chromophores on post-
Golgi membranes. We presume that the misfolded M-opsin is
exported from the ER to the cytoplasm by the endoplasmic
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1523reticulum associated degradation pathway for destruction by
the proteasome in the cytoplasm in Rpe65−/− mice.
In summary, we conclude that M-opsin protein may be
degraded via the proteasome pathway, and the degradation
was inhibited with 9-cis-retinal treatment in the Rpe65−/− mice
retina  to  some  extent.  This  study  demonstrated  that
chromophore-free  M-opsin  is  degraded  quickly  and
chromophores have a crucial role in M-opsin stabilization as
the ligands in the mouse retina.
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